Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
- PMID: 22101602
- DOI: 10.1038/nchembio.719
Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
Abstract
Several lines of evidence indicate that prefibrillar assemblies of amyloid-β (Aβ) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of Aβ fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in Aβ peptides and stabilizes the self-assembly of seeding-competent, β-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic Aβ oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by Aβ oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.
Similar articles
-
Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.J Biol Chem. 2010 Feb 26;285(9):6071-9. doi: 10.1074/jbc.M109.069542. Epub 2009 Dec 15. J Biol Chem. 2010. PMID: 20018889 Free PMC article.
-
Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.J Biomed Sci. 2012 Dec 21;19(1):104. doi: 10.1186/1423-0127-19-104. J Biomed Sci. 2012. PMID: 23259691 Free PMC article.
-
Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.J Neurosci. 2005 Feb 2;25(5):1071-80. doi: 10.1523/JNEUROSCI.2381-04.2005. J Neurosci. 2005. PMID: 15689542 Free PMC article.
-
Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.Eur J Med Chem. 2016 May 23;114:41-58. doi: 10.1016/j.ejmech.2016.02.065. Epub 2016 Mar 2. Eur J Med Chem. 2016. PMID: 26974374 Review.
-
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030. Ann N Y Acad Sci. 2005. PMID: 16533927 Review.
Cited by
-
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease.Int J Mol Sci. 2021 Feb 25;22(5):2283. doi: 10.3390/ijms22052283. Int J Mol Sci. 2021. PMID: 33668976 Free PMC article. Review.
-
In Vitro Biosensing of β-Amyloid Peptide Aggregation Dynamics using a Biological Nanopore.Sens Actuators B Chem. 2021 Jul 1;338:129863. doi: 10.1016/j.snb.2021.129863. Epub 2021 Mar 29. Sens Actuators B Chem. 2021. PMID: 33927481 Free PMC article.
-
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.Br J Pharmacol. 2012 Sep;167(2):324-52. doi: 10.1111/j.1476-5381.2012.02057.x. Br J Pharmacol. 2012. PMID: 22646481 Free PMC article. Review.
-
Spontaneous Formation of β-sheet Nano-barrels during the Early Aggregation of Alzheimer's Amyloid Beta.Nano Today. 2021 Jun;38:101125. doi: 10.1016/j.nantod.2021.101125. Epub 2021 Mar 13. Nano Today. 2021. PMID: 33936250 Free PMC article.
-
Layers of structure and function in protein aggregation.Nat Chem Biol. 2015 Jun;11(6):373-7. doi: 10.1038/nchembio.1818. Nat Chem Biol. 2015. PMID: 25978986 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources